IMAFLEX INC (IFX.CA) Fundamental Analysis & Valuation

TSX-V:IFX • CA4524352099

Current stock price

2.34 CAD
0 (0%)
Last:

This IFX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IFX.CA Profitability Analysis

1.1 Basic Checks

  • IFX had positive earnings in the past year.
  • In the past year IFX had a positive cash flow from operations.
  • In the past 5 years IFX has always been profitable.
  • Each year in the past 5 years IFX had a positive operating cash flow.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

  • IFX's Return On Assets of 1.47% is in line compared to the rest of the industry. IFX outperforms 42.86% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.06%, IFX is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • With a Return On Invested Capital value of 4.96%, IFX perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for IFX is in line with the industry average of 8.77%.
Industry RankSector Rank
ROA 1.47%
ROE 2.06%
ROIC 4.96%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.24%, IFX is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • IFX's Profit Margin has improved in the last couple of years.
  • IFX has a Operating Margin of 4.57%. This is in the lower half of the industry: IFX underperforms 71.43% of its industry peers.
  • In the last couple of years the Operating Margin of IFX has grown nicely.
  • IFX's Gross Margin of 14.54% is on the low side compared to the rest of the industry. IFX is outperformed by 71.43% of its industry peers.
  • In the last couple of years the Gross Margin of IFX has grown nicely.
Industry RankSector Rank
OM 4.57%
PM (TTM) 1.24%
GM 14.54%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IFX.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IFX is destroying value.
  • The number of shares outstanding for IFX remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for IFX has been increased compared to 5 years ago.
  • IFX has a better debt/assets ratio than last year.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • IFX has an Altman-Z score of 5.27. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
  • IFX has a Altman-Z score of 5.27. This is amongst the best in the industry. IFX outperforms 85.71% of its industry peers.
  • IFX has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.78, IFX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that IFX is not too dependend on debt financing.
  • IFX has a Debt to Equity ratio of 0.10. This is in the better half of the industry: IFX outperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.78
Altman-Z 5.27
ROIC/WACC0.62
WACC8.02%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • IFX has a Current Ratio of 2.53. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
  • IFX has a Current ratio of 2.53. This is in the better half of the industry: IFX outperforms 71.43% of its industry peers.
  • IFX has a Quick Ratio of 1.72. This is a normal value and indicates that IFX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.72, IFX is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 1.72
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IFX.CA Growth Analysis

3.1 Past

  • The earnings per share for IFX have decreased strongly by -77.93% in the last year.
  • IFX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.43% yearly.
  • IFX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.32%.
  • Measured over the past years, IFX shows a small growth in Revenue. The Revenue has been growing by 6.26% on average per year.
EPS 1Y (TTM)-77.93%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-64.33%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-3.28%

3.2 Future

  • Based on estimates for the next years, IFX will show a very strong growth in Earnings Per Share. The EPS will grow by 116.02% on average per year.
  • IFX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.80% yearly.
EPS Next Y33.33%
EPS Next 2Y116.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

More info and screens

Find the best growth stocksShow best growing peers

3

4. IFX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 78.00, IFX can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, IFX is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, IFX is valued quite expensively.
  • A Price/Forward Earnings ratio of 16.23 indicates a correct valuation of IFX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IFX is on the same level as its industry peers.
  • IFX is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 78
Fwd PE 16.23
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IFX is valued a bit more expensive than 71.43% of the companies in the same industry.
  • IFX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 10.95
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as IFX's earnings are expected to grow with 116.02% in the coming years.
PEG (NY)2.34
PEG (5Y)2.14
EPS Next 2Y116.02%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IFX.CA Dividend Analysis

5.1 Amount

  • No dividends for IFX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IFX.CA Fundamentals: All Metrics, Ratios and Statistics

IMAFLEX INC

TSX-V:IFX (2/27/2026, 7:00:00 PM)

2.34

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)11-27
Earnings (Next)04-22
Inst Owners19.43%
Inst Owner ChangeN/A
Ins Owners3.38%
Ins Owner ChangeN/A
Market Cap121.89M
Revenue(TTM)108.00M
Net Income(TTM)1.34M
Analysts84.44
Price Target1.73 (-26.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-83.82%
Min EPS beat(2)-100%
Max EPS beat(2)-67.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.78%
Min Revenue beat(2)-16.54%
Max Revenue beat(2)-7.03%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-71.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.09%
Valuation
Industry RankSector Rank
PE 78
Fwd PE 16.23
P/S 1.13
P/FCF 11.23
P/OCF 8.59
P/B 1.88
P/tB 1.95
EV/EBITDA 10.95
EPS(TTM)0.03
EY1.28%
EPS(NY)0.14
Fwd EY6.16%
FCF(TTM)0.21
FCFY8.91%
OCF(TTM)0.27
OCFY11.64%
SpS2.07
BVpS1.24
TBVpS1.2
PEG (NY)2.34
PEG (5Y)2.14
Graham Number0.915814 (-60.86%)
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 2.06%
ROCE 6.65%
ROIC 4.96%
ROICexc 5.91%
ROICexgc 6.14%
OM 4.57%
PM (TTM) 1.24%
GM 14.54%
FCFM 10.05%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexgc growth 3Y-20.84%
ROICexgc growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score4
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.78
Debt/EBITDA 0.58
Cap/Depr 56.61%
Cap/Sales 3.08%
Interest Coverage 8.8
Cash Conversion 131.19%
Profit Quality 812.89%
Current Ratio 2.53
Quick Ratio 1.72
Altman-Z 5.27
F-Score4
WACC8.02%
ROIC/WACC0.62
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.93%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-64.33%
EPS Next Y33.33%
EPS Next 2Y116.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-3.28%
Revenue Next Year11.68%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.66%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year70.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y280.88%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y100.18%
OCF growth 3Y25.19%
OCF growth 5Y10.31%

IMAFLEX INC / IFX.CA Fundamental Analysis FAQ

What is the fundamental rating for IFX stock?

ChartMill assigns a fundamental rating of 5 / 10 to IFX.CA.


What is the valuation status of IMAFLEX INC (IFX.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to IMAFLEX INC (IFX.CA). This can be considered as Overvalued.


What is the profitability of IFX stock?

IMAFLEX INC (IFX.CA) has a profitability rating of 5 / 10.


What is the valuation of IMAFLEX INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IMAFLEX INC (IFX.CA) is 78 and the Price/Book (PB) ratio is 1.88.


What is the financial health of IMAFLEX INC (IFX.CA) stock?

The financial health rating of IMAFLEX INC (IFX.CA) is 7 / 10.